Black Hawk Acquisition Stock Price, News & Analysis
Company Description
Black Hawk Acquisition (NASDAQ: BKHAR) is a publicly traded company in the Biological Products, (no Diagnostic Substances) sector.
BKHAR stock has declined 10.0% over the past year. Shares last traded at $1.35.
On a trailing twelve-month basis, Black Hawk Acquisition reported net income of $1.3M.
This page provides a comprehensive overview of BKHAR stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Black Hawk Acquisition (BKHAR) stock last traded at $1.35. Over the past 12 months, the stock has lost 10.0%.
Latest News
SEC Filings
Black Hawk Acquisition has filed 4 recent SEC filings, including 3 Form 8-K, 1 Form S-4/A. The most recent filing was submitted on April 1, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BKHAR SEC filings →
Financial Highlights
operating income reached -$916K, and net income was $1.3M. The company generated -$650K in operating cash flow. With a current ratio of 0.03, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Black Hawk Acquisition (BKHAR) currently stands at 70 shares, down 97.5% from the previous reporting period. Over the past 12 months, short interest has decreased by 91.1%.
Days to Cover History
Days to cover for Black Hawk Acquisition (BKHAR) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 24.5 days.
BKHAR Company Profile & Sector Positioning
Black Hawk Acquisition (BKHAR) operates in the Biological Products, (no Diagnostic Substances) sector and is listed on the NASDAQ.